PTEN loss leads to AKT- and CDK1- or CDK2-mediated phosphorylation of FOXO1, exclusion of FOXO1 protein from the nucleus, and loss of its tumor suppressor functions in the nucleus 18, 25-27. The gene discussed is FOXO1; the disease is neoplasm.